Intestinal Epithelium Adhesion Sites

Intestinal Epithelium Adhesion Sites refer to the collective molecular and structural components on the luminal surface of the intestine that facilitate the attachment of microorganisms and maintain the integrity of the epithelial barrier (NIH, 2020). These sites include the mucus layer (primarily mucins like MUC2), the glycocalyx (surface glycans and glycoproteins), and junctional complexes such as tight junctions (claudins, occludin) and adherens junctions (E-cadherin) (PubMed). In a therapeutic context, these sites are the primary targets for probiotics and commensal bacteria, which utilize them for colonization and to provide competitive exclusion against enteric pathogens like Salmonella or Clostridium difficile (ResearchGate, 2025). By occupying these adhesion sites, beneficial microbes prevent pathogen attachment and subsequent invasion or toxin release (wjgnet.com). Additionally, pharmacological agents and certain probiotic strains can modulate these sites by upregulating the expression of tight junction proteins, thereby strengthening the intestinal barrier and reducing symptoms associated with increased intestinal permeability in inflammatory bowel disease (IBD) and other gastrointestinal disorders (NIH, 2020). Specific molecules like MAdCAM-1 also serve as adhesion sites for immune cells, making them targets for biologics like vedolizumab in treating chronic inflammation (PubMed).

Other names

Gut adhesion sitesIntestinal attachment sitesMucosal adhesion sitesEpithelial binding sitesIntestinal epithelial cell adhesion sites

Competitive exclusion of pathogens from epithelial binding sites and upregulation of tight junction proteins to enhance intestinal barrier integrity.